Inventor
Sanjeev Gangwar
Inventor
Foster City, CA, US
Overview
Patents· 69 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds21%
C07KPeptides15%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
B82YSpecific uses or applications of nanostructures2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02PClimate change mitigation technologies in the production or processing of goods0%
PatentTitleYear
11,020,490Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit202110,981,914Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor202110,941,145Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor202110,927,114Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor202110,919,895Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor202110,913,741Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor202110,898,578Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making202110,889,590Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents202110,869,934Antiproliferative compounds and conjugates made therefrom202010,793,569Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor202010,723,736Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor202010,711,003Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor202010,696,676Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor202010,689,382Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor202010,508,115Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor201910,494,370Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor201910,487,084Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor201910,472,361Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor201910,457,681Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor201910,398,783Antiproliferative compounds and conjugates made therefrom201910,287,291Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use201910,279,049Antibody-drug conjugates of tubulysin analogs with enhanced stability201910,233,192Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents201910,112,975Benzodiazepine dimers, conjugates thereof, and methods of making and using201810,077,287Tubulysin analogs and methods of making and use20189,822,112'Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using'20179,822,144'Benzodiazepine dimers, conjugates thereof, and methods of making and using'20179,777,013'Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents'20179,688,721'Tubulysin compounds, methods of making and use'20179,676,794'Benzodiazepine dimers, conjugates thereof, and methods of making and using'20179,676,775'Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using'20179,580,467'Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof'20179,527,871'Benzodiazepine dimers, conjugates thereof, and methods of making and using'20169,526,801'Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using'20169,382,289'Tubulysin compounds, methods of making and use'20169,226,974'Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof'20169,186,416'Immunoconjugates, compositions for making them, and methods of making and use'20159,156,850'Enediyne compounds, conjugates thereof, and uses and methods therefor'20159,109,008'Tubulysin compounds, methods of making and use'20158,980,824'Tubulysin compounds, methods of making and use'20158,852,599'Immunoconjugates, compositions for making them, and methods of making and use'20148,802,632'Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof'20148,772,542'Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof'20148,772,543'Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof'20148,709,431'Enediyne compounds, conjugates thereof, and uses and methods therefor'20148,664,407'Chemical linkers with single amino acids and conjugates thereof'20148,461,117'Chemical linkers and cleavable substrates and conjugates thereof'20138,399,403'Chemical linkers and conjugates thereof'20138,394,922'Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof'20138,034,787'Enzyme-cleavable prodrug compounds'20117,977,465'Peptidyl prodrugs and linkers and stabilizers useful therefor'20117,968,586'Cytotoxic compounds and conjugates'20117,847,105'Methods and compounds for preparing CC-1065 analogs'20107,816,317'Tripeptide prodrug compounds'20107,771,962'CD10-activated prodrug compounds'20107,714,016'Cytotoxic compounds and conjugates with cleavable substrates'2010RE041252'Peptidyl prodrugs and linkers and stabilizers useful therefor'20107,696,313'Prodrug compounds with isoleucine'20107,691,962'Chemical linkers and conjugates thereof'20107,517,903'Cytotoxic compounds and conjugates'20097,507,420'Peptidyl prodrugs and linkers and stabilizers useful therefor'20097,425,541'Enzyme-cleavable prodrug compounds'20087,329,507'Prodrug compounds with isoleucine'20087,304,032'CD-10 activated prodrug compounds'20077,214,663'Tripeptide prodrug compounds'20077,115,573'Prodrug compounds with an isoleucine'20067,087,600'Peptidyl prodrugs and linkers and stabilizers useful therefor'20066,897,034'CD10-activated prodrug compounds'20055,672,584'Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997Based in Lawrence, KS, US· patent location history
2005–2014Patents assigned to MEDAREX INC (25)· patent assignee history
2005–2011Based in San Mateo, CA, US· patent location history
2006–2008Based in Alameda, CA, US· patent location history
2010–2021Based in Foster City, CA, US· patent location history
2013–2014Patents assigned to GANGWAR SANJEEV (5)· patent assignee history
2014–2021Patents assigned to BRISTOL MYERS SQUIBB CO (40)· patent assignee history
2014Patents assigned to MEDAREX LLC (4)· patent assignee history
2017–2021Patents assigned to SCRIPPS RESEARCH INST (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 40 | 2014–2021 |
| MEDAREX INC | 25 | 2005–2014 |
| GANGWAR SANJEEVself | 5 | 2013–2014 |
| MEDAREX LLC | 4 | 2014 |
| SCRIPPS RESEARCH INST | 4 | 2017–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Foster City, California, US | 54 | 2010–2021 |
| San Mateo, California, US | 9 | 2005–2011 |
| Alameda, California, US | 5 | 2006–2008 |
| Lawrence, KS, US | 1 | 1997 |